A Comparison of Study Population Inclusion and Exclusion Criteria reported in Advanced Stage Clinical Trial Protocols
by Paul Oloo
19th November 2020 •
comment
9th November 2020 •
comment
COVID-19 Efficacy Endpoints in Interventional Trials: What Constitutes an Incident Clinical Disease Case and What Triggers Diagnostic Work-Up V2.0
by Edde Loeliger & Amol Chaudhari
20th October 2020 •
comment
Early and Advanced Stage Clinical Development Core Elements- Comparison of the Guidance and Considerations
by Paul Oloo
3rd September 2020 •
comment
Considerations for Inclusion of Risk Populations into COVID-19 Vaccine Efficacy Trials
by Paul Oloo & Edde Loeliger
17th July 2020 •
comment
1st July 2020 •
comment
Core Elements for Advanced Stage Clinical Trials of COVID-19 Vaccine Candidates: Aspects to Consider
by Amol Chaudhari
26th June 2020 •
comment
Efficacy Endpoints in COVID-19 Vaccine Trials: SARS-CoV-2 Infection
by Amol Chaudhari & Edde Loeliger
25th June 2020 •
comment
Submit an article
We welcome contributions from members. Please submit an article for review by our editorial team.
Upload nowCategories
- Clinical trials (8)
- Coronavirus (4)
- COVID-19 (WEPHREN Resources) (17)
- Infectious diseases (2)
- Lassa Fever (2)
- Maternal Health (1)
- Participatory Epidemiology (1)
- Vacancy (1)
- Vacccine Production (3)
- Vaccine Efficacy (6)
- Vaccine safety (9)
- West Africa (1)
- Workshop Reports (4)